Veterinary advice should be sought before applying any treatment or vaccine.
Therapies | Details | |
---|---|---|
Radiotherapy | Uses ionising radiation to kill neoplastic cells by damaging DNA and protein. | |
Cryosurgery | Involves the application of liquid nitrogen at -196 degrees Celsius either by spray or probe, to destroy tumor cells through the formation of intracellular ice and subsequent rupture of cell membranes | C Rothacker et al., 2015 |
Bioabsorbable cisplatin beads | 91% (20/22) of horses with a 2-year follow up after treatment had complete resolution of the tumor. | C Hewes 2007 |
Electrochemotherapy (ECT) | A anticancer therapy that uses electrical field pulses to induce increased cell membrane permeability to antitumour hydrophilic drugs, such as cisplatin. Studies show ECT therapy was 99.5% (193/194) effective for sarcoid removal, for at least 4 years. However the size of the sarcoid significantly influenced the number of treatments required for its complete removal. | Y Tamzali et al., 2012;C Rothacker et al., 2015 |
Interstitial brachytherapy | Also known as internal radiation therapy. It works through the use of a radiation source that is sealed in an implant and placed in or near the sarcoid. | C Rothacker et al., 2015 |
Topical herbal preparations | C Rothacker et al., 2015 | |
Topical ointments | Daily topical application of 5% aciclovir cream for 2-6 months caused complete tumor remission for 68% (32/47) of horses with mild-type sarcoids; with no recurrences reported. | S Stadler et al., 2011; C Rothacker et al., 2015 |
Surgical removal | Using a laser, 83% (82/92) of horses showed no recurrence of the sarcoid removed. Horses with verrucose sarcoids were the form at an increased risk of recurrence. | PC Compston et al., 2015; C Rothacker et al., 2015 |
Immunotherapy | Relies on local immune stimulation with the use of Chimeric virus-like particles (CVLPs) of BPV 1 L1-E7 or Bacillus Calmette-Guerin (BCG) cell wall extract as an intralesional injection to induce an immunological response | C Rothacker et al., 2015; S Mattil-Fritz et al., 2008 |
Autologous Vaccine | Multiple types are available. One type developed in Canada is based on the polymerization of antigenic tumor markers. 90% (19/21) horses that had this procedure had complete remission of the sarcoid. A second autologous vaccine developed by Epsy in 2008 can be performed in the field using sarcoid tissue frozen in liquid nitrogen and implanted back into the horse in subcutaneous pockets in the neck. This second vaccine showed an 80% (12/15) success rate for complete tumor regression | C Rothacker et al., 2015 |